13 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
given to such term in Section 0 of this Agreement.
“Quality Agreement” has the meaning given to such term in Section 7.4 of this Agreement.
“Recall … ” means with respect to the Product, a “recall”, “correction” or “market” withdrawal, as those terms (or their equivalents) are defined by Applicable Law
6-K
FENC
Fennec Pharmaceuticals Inc
22 Jul 05
Current report (foreign)
12:00am
responsibility for and will make all decisions with respect to any recall, market withdrawal or other corrective action related to Products (collectively, “Recall … ”);
(ii) Adherex will, as soon as practicable, notify GGL of any Recall information received by Adherex in reasonable detail;
(iii) Adherex
424B5
FENC
Fennec Pharmaceuticals Inc
30 Oct 20
Prospectus supplement for primary offering
4:32pm
to recall or withdraw a product as a result of newly discovered safety or efficacy concerns, either of which would have a materially adverse effect on our
8-K
EX-1.1
gjdock
30 Oct 20
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-1.1
tql7t46zcxhl6c9prdr
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
- Prev
- 1
- Next